v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 73,371 $ 98,817
Restricted cash 128,964 105,000
Loans receivable at fair value 2,985,129 3,143,653
Interest and fees receivable, net 30,852 31,796
Capitalized software and other intangibles, net 133,012 139,801
Right of use assets - operating 26,515 30,448
Other assets 94,200 64,180
Total assets 3,472,043 3,613,695
Liabilities    
Secured financing 486,453 317,568
Asset-backed notes at fair value 2,118,786 2,387,674
Asset-backed borrowings at amortized cost 25,600 0
Acquisition and corporate financing 271,507 222,879
Lease liabilities 33,124 37,947
Other liabilities 78,175 100,028
Total liabilities 3,013,645 3,066,096
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at June 30, 2023 and December 31, 2022; 34,299,366 shares issued and 34,027,343 shares outstanding at June 30, 2023; 33,626,630 shares issued and 33,354,607 shares outstanding at December 31, 2022 7 7
Common stock, additional paid-in capital 575,587 547,799
Retained earnings (accumulated deficit) (110,887) 6,102
Treasury stock at cost, 272,023 shares at June 30, 2023 and December 31, 2022 (6,309) (6,309)
Total stockholders’ equity 458,398 547,599
Total liabilities and stockholders' equity $ 3,472,043 $ 3,613,695

Source

HTML PDF
XBRL
ZIP